Concordance of c‐kit Mutational Status in Matched Primary and Metastatic Cutaneous Canine Mast Cell Tumors at Baseline

BACKGROUND: Mutation analysis of proto‐oncogene c‐kit (c‐kit) is advisable before starting treatment with tyrosine kinase inhibitors in dogs with mast cell tumor (MCT), including those with metastatic disease. Testing is usually performed on primary tumors, assuming that c‐kit mutation status does n...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconato, L., Zorzan, E., Giantin, M., Di Palma, S., Cancedda, S., Dacasto, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Standard Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858004/
https://www.ncbi.nlm.nih.gov/pubmed/24372836
http://dx.doi.org/10.1111/jvim.12266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858004/
https://www.ncbi.nlm.nih.gov/pubmed/24372836
http://dx.doi.org/10.1111/jvim.12266

Ejemplares similares